PSA has begun a review of its Professional Guidelines for the revised pharmacy programs
These programs include those for Dose Administration Aids, MedsCheck/Diabetes MedsCheck, Staged Supply and Home Medicines Review services, announced by the Federal Government in the 2017-18 Budget.
PSA’s Professional Guidelines set the expected professional standard and outline best practice for pharmacists providing services under these programs, says project advisory chair Grant Kardachi.
The work is part of a regular cycle of reviews undertaken to ensure these documents reflect contemporary pharmacist practice, and support the Quality Use of Medicines and delivery of consistent, high-quality standards of pharmacist care to Australian health consumers.
A Project Advisory Group (PAG) of key stakeholders (pharmacy, Government and consumers) has been established.
The PAG held its first meeting last week to determine the strategic direction for the reviews.
The PAG agreed:
- The revised Guidelines will reinforce PSA’s focus on patient-centred, collaborative care, and outline the requirements of contemporary pharmacist practice.
- The revised Guidelines will highlight new program requirements, and communicate the important role that data collection will play in future program evaluation.
- The review should promote useability and consistency across the Guidelines and articulate the linkages between programs.
- There needs to be a strong focus on supporting the implementation of the revised programs in practice through the development of practice support and education tools, and the identification of linkages to other key guidance documents (e.g. Professional Practice Standards, Competency Standards and Code of Ethics for Pharmacists).
The revised Guidelines for Dose Administration Aids, MedsCheck/Diabetes MedsCheck and Staged Supply services are scheduled for release in late October 201 (with Guidelines for Home Medicines Review service scheduled for later in the year) and will be followed by the staged roll-out of an associated practice support and education program for pharmacists.
Funding for the work has been provided by the Federal Department of Health.